The Onset of Monoclonal and Oligoclonal Gammopathies Is a Good Prognostic Factor after Allogeneic Stem Cell Transplantation.

The Onset of Monoclonal and Oligoclonal Gammopathies Is a Good Prognostic Factor after Allogeneic Stem Cell Transplantation. Acta Haematol. 2018 Nov 15;141(1):7-11 Authors: Iovino L, Mazziotta F, Buda G, Orciuolo E, Caracciolo F, Pelosini M, Morganti R, Galimberti S, Benedetti E, Petrini M PMID: 30439709 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30439709?dopt=Abstract

Source: Acta Haematologica - November 15, 2018 Category: Hematology Authors: Iovino L, Mazziotta F, Buda G, Orciuolo E, Caracciolo F, Pelosini M, Morganti R, Galimberti S, Benedetti E, Petrini M Tags: Acta Haematol Source Type: research

More News: Hematology | Stem Cell Therapy | Stem Cells | Transplants